Table 3.
Details of Study Participants in Group II and Group III
| Clinical Appearance Group II | ||||
|---|---|---|---|---|
| Thin smooth | Thick fissured | Granular verruciform | Erythro-leukoplakia | |
| No. of Cases | 3 | 33 | 1 | 13 |
| Positive crystallization | 3 | 24 | 1 | 12 |
| Histopathological Diagnosis Group II | ||||
| Hyperkeratosis with no dysplasia | Mild dysplasia | Moderate dysplasia | Severe dysplasia | |
| No of case | 3 | 34 | 12 | 1 |
| Positive crystallization | 2 | 26 | 11 | 1 |
| Clinical Staging Group III | ||||
| TNM Stage I | TNM Stage II | TNM Stage III | TNM Stage IV | |
| No. of cases | 10 | 26 | 16 | 13 |
| Positive crystallization | 9 | 25 | 15 | 12 |
| Histopathological Diagnosis Group III | ||||
| Well differentiated SCC | Moderately differentiated SCC | |||
| No. of cases | 41 | 24 | ||
| Positive crystallization | 38 (92.68%) | 23 (95.83%) | ||